Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 8,627,972
- Share change
- +4,388,702
- Total reported value
- $18,126,000
- Put/Call ratio
- 57%
- Price per share
- $2.10
- Number of holders
- 22
- Value change
- +$8,662,521
- Number of buys
- 16
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$7,666,000 | — | 30 Sep 2016 | |
| Abingworth LLP |
13F
|
Company |
0.33%
|
437,994
|
$1,375,000 | — | 30 Sep 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
375,309
|
$1,130,000 | — | 30 Sep 2016 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.28%
|
373,209
|
$1,123,000 | — | 30 Sep 2016 | |
| Redmile Group, LLC |
13F
|
Company |
0.14%
|
187,610
|
$565,000 | — | 30 Sep 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
85,100
|
$256,000 | — | 30 Sep 2016 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
69,360
|
$209,000 | — | 30 Sep 2016 | |
| Creative Planning |
13F
|
Company |
0.05%
|
60,000
|
$181,000 | — | 30 Sep 2016 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.04%
|
50,872
|
$153,000 | — | 30 Sep 2016 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
16,345
|
$49,000 | — | 30 Sep 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
15,236
|
$46,000 | — | 30 Sep 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
10,793
|
$32,000 | — | 30 Sep 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
7,500
|
$23,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,099
|
$6,000 | — | 30 Sep 2016 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2016
As of 31 Dec 2016,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,627,972 shares.
The largest 10 holders included
NEA Management Company, LLC, GOLDMAN SACHS GROUP INC, ACUTA CAPITAL PARTNERS, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Anson Funds Management LP, SG Americas Securities, LLC, K2 PRINCIPAL FUND, L.P., OXFORD ASSET MANAGEMENT, UBS Group AG, and MILLENNIUM MANAGEMENT LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
14
Q4 2016 holders
22
Holder diff
8
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.